The effect of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohorts

Gynecologic Oncology

Volumn 140, Issue 2, 2016, Pages 270-276

  Al Hilli, Mariam M ^a   Bakkum Gamez, Jamie N ^a   Mariani, Andrea ^a   Cliby, William A ^a   Mc Gree, Michaela E ^a   Weaver, Amy L ^a   Dowdy, Sean C ^a   Podratz, Karl C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Abbreviations DM diabetes mellitus; EC endometrial cancer; HR hazard ratio; OS overall survival; PFS progression free survival; PS propensity score

Indexed keywords

INSULIN; METFORMIN; ANTIDIABETIC AGENT;

ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; DIABETES MELLITUS; DIABETIC PATIENT; ENDOMETRIUM CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL HISTORY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; AGED; DISEASE FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; MIDDLE AGED; MINNESOTA;

AGED; COHORT STUDIES; DIABETES MELLITUS; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; MIDDLE AGED; MINNESOTA; RETROSPECTIVE STUDIES;

EID: 84949033605     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.11.019     Document Type: Article

References (32)

1. R. Siegel, J. Ma, Z. Zou, and A. Jemal Cancer statistics, 2014. CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29. Epub 2014 Jan 7. Erratum in CA Cancer J. Clin. 64 5 2014 Sep-Oct 364
2. F. Amant, P. Moerman, P. Neven, D. Timmerman, E. Van Limbergen, and I. Vergote Endometrial cancer Lancet 366 9484 2005 Aug 6-12 491 505
3. E. Friberg, C.S. Mantzoros, and A. Wolk Diabetes and risk of endometrial cancer: a population-based prospective cohort study Cancer Epidemiol. Biomark. Prev. 16 2 2007 Feb 276 280
4. E. Friberg, N. Orsini, C.S. Mantzoros, and A. Wolk Diabetes mellitus and risk of endometrial cancer: a meta-analysis Diabetologia 50 7 2007 Jul 1365 1374 Epub 2007 May 3
5. A.N. Fader, L.N. Arriba, H.E. Frasure, and V.E. von Gruenigen Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship Gynecol. Oncol. 114 1 2009 Jul 121 127 Epub 2009 Apr 29
6. V.M. Chia, P.A. Newcomb, A. Trentham-Dietz, and J.M. Hampton Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis Int. J. Gynecol. Cancer 17 2 2007 Mar-Apr 441 446
7. Y. Zhang, Z. Liu, X. Yu, X. Zhang, S. Lu, X. Chen, and et al. The association between metabolic abnormality and endometrial cancer: a large case-control study in China Gynecol. Oncol. 117 1 2010 Apr 41 46 Epub 2010 Jan 22
8. American Diabetes Association Executive summary: standards of medical care in diabetes - 2014 Diabetes Care 37 Suppl 1 2014 Jan S5 13
9. S. Palomba, A. Falbo, F. Zullo, and F. Orio Jr. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review Endocr. Rev. 30 1 2009 Feb 1 50 Epub 2008 Dec 4
10. B.K. Tan, R. Adya, J. Chen, H. Lehnert, L.J. Sant Cassia, and H.S. Randeva Metformin treatment exerts antiinvasive and antimetastatic effects in human endometrial carcinoma cells J. Clin. Endocrinol. Metab. 96 3 2011 Mar 808 816 Epub 2010 Dec 29
11. L.A. Cantrell, C. Zhou, A. Mendivil, K.M. Malloy, P.A. Gehrig, and V.L. Bae-Jump Metformin is a potent inhibitor of endometrial cancer cell proliferation: implications for a novel treatment strategy Gynecol. Oncol. 116 1 2010 Jan 92 98 Epub 2009 Oct 12
12. M.R. Owen, E. Doran, and A.P. Halestrap Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain Biochem. J. 348 Pt 3 2000 Jun 15 607 614
13. E.M. Ko, P. Walter, A. Jackson, L. Clark, J. Franasiak, C. Bolac, and et al. Metformin is associated with improved survival in endometrial cancer Gynecol. Oncol. 132 2 2014 Feb 438 442 Epub 2013 Nov 22
14. N.S. Nevadunsky, A. Van Arsdale, H.D. Strickler, A. Moadel, G. Kaur, M. Frimer, and et al. Metformin use and endometrial cancer survival Gynecol. Oncol. 132 1 2014 Jan 236 240 Epub 2013 Nov 2
15. M.M. AlHilli, J.N. Bakkum-Gamez, A. Mariani, A.L. Weaver, M.E. McGree, G.L. Keeney, and et al. Risk-adjusted outcomes in elderly endometrial cancer patients: implications of the contrasting impact of age on progression-free and cause-specific survival Gynecol. Oncol. 138 1 2015 Jul 133 140 Epub 2015 Apr 17
16. B.L. Hall, B.H. Hamilton, K. Richards, K.Y. Bilimoria, M.E. Cohen, and C.Y. Ko Does surgical quality improve in the American College of Surgeons National Surgical Quality Improvement Program: an evaluation of all participating hospitals Ann. Surg. 250 3 2009 Sep 363 376
17. S.F. Khuri, J. Daley, and W.G. Henderson The comparative assessment and improvement of quality of surgical care in the Department of Veterans Affairs Arch. Surg. 137 1 2002 Jan 20 27
18. P.S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int. J. Gynaecol. Obstet. 2009 May;105(2):103-4. Erratum in Int. J. Gynaecol. Obstet. 108 2 2010 Feb 176
19. R. Scully, and et al. WHO-histological typing of female genital-tract tumors Ann. Pathol. 15 4 1995 296 297
20. J.A. Ferreiro, J.L. Myers, and D.G. Bostwick Accuracy of frozen section diagnosis in surgical pathology: review of a 1-year experience with 24,880 cases at Mayo Clinic Rochester Mayo Clin. Proc. 70 12 1995 Dec 1137 1141
21. A. Mariani, S.C. Dowdy, W.A. Cliby, B.S. Gostout, M.B. Jones, T.O. Wilson, and et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging Gynecol. Oncol. 109 1 2008 Apr 11 18 Epub 2008 Mar 4
22. A. Mariani, M.J. Webb, G.L. Keeney, M.G. Haddock, G. Calori, and K.C. Podratz Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am. J. Obstet. Gynecol. 182 6 2000 Jun 1506 1519
23. K.K. Tsilidis, and J.P. Ioannidis Authors' reply to editorial linked to their umbrella review of meta-analyses of observational studies on type 2 diabetes and cancer BMJ 350 2015 Feb 11 h711
24. E. Giovannucci, D.M. Harlan, M.C. Archer, R.M. Bergenstal, S.M. Gapstur, L.A. Habel, and et al. Diabetes and cancer: a consensus report Diabetes Care 33 7 2010 Jul 1674 1685
25. K.K. Tsilidis, J.C. Kasimis, D.S. Lopez, E.E. Ntzani, and J.P. Ioannidis Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies BMJ 350 2015 Jan 2 g7607
26. J.A. Johnson, B. Carstensen, D. Witte, S.L. Bowker, L. Lipscombe, A.G. Renehan, and Diabetes and Cancer Research Consortium Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence Diabetologia 55 6 2012 Jun 1607 1618 Epub 2012 Apr 4
27. A.G. Renehan, H.C. Yeh, J.A. Johnson, S.H. Wild, E.A. Gale, H. Moller, and Diabetes and Cancer Research Consortium Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer Diabetologia 55 6 2012 Jun 1619 1632 Epub 2012 Apr 4
28. Z.H. Zhang, P.Y. Su, J.H. Hao, and Y.H. Sun The role of preexisting diabetes mellitus on incidence and mortality of endometrial cancer: a meta-analysis of prospective cohort studies Int. J. Gynecol. Cancer 23 2 2013 Feb 294 303
29. Z.J. Zhang, and S. Li The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis Diabetes Obes Metab 16 8 2014 Aug 707 710 Epub 2014 Feb 27
30. A. Mitsuhashi, T. Kiyokawa, Y. Sato, and M. Shozu Effects of metformin on endometrial cancer cell growth in vivo: a preoperative prospective trial Cancer 120 19 2014 Oct 1 2986 2995 Epub 2014 Jun 10
31. C.J. Currie, C.D. Poole, S. Jenkins-Jones, E.A. Gale, J.A. Johnson, and C.L. Morgan Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival Diabetes Care 35 2 2012 Feb 299 304 Epub 2012 Jan 20
32. C. Liao, D. Zhang, C. Mungo, D.A. Tompkins, and A.M. Zeidan Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies Gynecol. Oncol. 135 1 2014 Oct 163 171 Epub 2014 Jul 27